Author: healthadmin

A new study reveals how antidepressants have opposite effects on different groups of serotonin-producing brain cells, providing new insight into why selective serotonin reuptake inhibitors (SSRIs) can cause unpleasant side effects at the start of treatment, but lead to symptom relief over time. Antidepressants are among the most widely prescribed drugs in the world. More than one in 10 people in Sweden currently uses antidepressants, with SSRIs being the most common type. However, surprisingly little is known about what these drugs actually do in the brain. Our study aimed to map the changes in gene expression that SSRIs cause…

The FDA has expanded the labeling of Pfizer’s subcutaneous hemophilia treatment Himpazi to include patients 6 years of age and older with hemophilia A or B. Anti-tissue factor pathway inhibitors were first approved in October 2024 for patients 12 years and older with hemophilia A or B who have not developed antibodies (also called inhibitors) produced by the immune system that block or destroy injected clotting factor drugs. The new expansion includes all patients 6 years of age and older, regardless of inhibitor status. With this new approval, treatment is now available to people aged 12 and older who develop…

Health tech company Elation Health has acquired startup Aster to advance the development of an agent AI operating system for primary care. Elation Health provides electronic medical records exclusively for primary care physicians. Launched in 2023, Aster is an AI-native EHR for women’s health that has developed technology that automates front office coordination and operational tasks through voice AI, including appointment scheduling, insurance verification, patient compliance, test result management, and care navigation. This is Elation’s second acquisition following its acquisition of Lightning MD in 2023. “Aster is a women’s health-focused EHR company built with AI at its core. The company…

Recent research published in scientific report provide evidence that combining multiple small psychological differences can accurately predict a person’s gender in 80% of cases. The findings suggest that a combination of these differences in cognition, personality, and interests may also help explain why certain occupations tend to be dominated by men or women. This study provides new insights into how subtle psychological changes shape real-world career trajectories. In psychological research, the differences between men and women generally tend to be small. When looking at individual characteristics, the range of scores for men and women overlaps widely. For example, women may…

What is the key to happiness? A growing body of research points to a seemingly simple answer: relationships. The Harvard Adult Development Study, one of the longest-running studies of adult life, found that strong relationships are central to health and well-being. And in order to have healthy relationships, we often need to have a good relationship with ourselves. But healthy relationships with friends, family, partners, classmates, coworkers, and ourselves don’t always develop naturally. they need jobs. That’s the idea behind Learning Sustainable Well-Being, a course at the University of California, San Diego and a campus-wide program that teaches students practical…

An international research team coordinated by the Medical University of Vienna has demonstrated in a clinical trial that administering torquetenovirus-induced immunosuppressants to kidney transplant recipients is safe. The results of the TTVguideIT study, recently presented at the annual meeting of the European Society of Nephrology, suggest that in the future immunosuppressive therapy may become more individualized, reducing treatment doses in certain patient groups. This study forms the central conclusion of the EU project TTVguideTX, coordinated by Gregor Bond from the Department of Nephrology and Dialysis, 3rd Faculty of Medicine, MedUni Vienna. After a kidney transplant, patients must take long-term medications…

Fever is something we encounter every day. A steaming cup of coffee gradually cools, a laptop warms up during use, and sunlight heats the earth’s surface. But when examining heat at distances much smaller than the width of a human hair, heat can behave unexpectedly. Researchers at Carnegie Mellon University, in collaboration with collaborators at Stanford University and Purdue University, have demonstrated a powerful new way to control heat at the nanoscale. Their findings were; naturewe provide strong experimental evidence that heat transfer can be intentionally manipulated and significantly enhanced using specially designed metamaterials. How heat moves across small gaps…

sauce: the future of the earth The space industry is experiencing rapid growth. Over the next few years, nearly 10,000 spacecraft are scheduled to be launched into low-Earth orbit for a variety of purposes, including “megaconstellations” of satellites providing global surveillance, space travel, and Internet services. Rocket engine exhaust, as well as the combustion of inactive satellites and rocket parts that re-enter Earth’s atmosphere, release an array of pollutants. Given the historically small size of the space industry, these chemicals have long been thought to pose little threat to the climate. Now, with the sector’s rapid growth, its emissions will…

Main findingsUsing pesticides in the home, having parents working with pesticides (especially in agriculture), and living near agricultural land were the exposures most frequently associated with childhood leukemia and brain tumors.The cancer risk was highest for those exposed to pesticides during pregnancy or early childhood, when children’s bodies and brains are still developing and are more sensitive to harmful chemicals.Studies have found that children exposed to these pesticides are nearly twice, and in some cases more than triple, likely to develop cancer, depending on the type, timing, and amount of exposure.When Yessica Ramirez was pregnant, she spent her days mixing…

Amgen aims to become the industry’s top player in cardiometabolic risk reduction by the beginning of the next decade, and last weekend the company attended the American Diabetes Association’s 2026 Scientific Sessions in New Orleans with multiple goals in mind. In one example, the company disclosed data aimed at strengthening the evidence supporting Repatha, a blockbuster cholesterol-lowering drug in high-risk patient subgroups, while executives also sought to stake a claim for Amgen’s obesity and diabetes pipeline asset, Maritide, against the existing hormone receptor agonist category. A highlight of the California drugmaker’s exhibit at this year’s ADA was new data from…